Concepedia

Josephine L. Klitgaard

JL

7

Publications

613

Citations

7

H-Index

2006

Active since

Affiliations

Dana-Farber Cancer Institute(Current)

Harvard University

Brigham and Women's Hospital

Symphogen (Denmark)

Rigshospitalet

Josephine L. Klitgaard is an author at Dana-Farber Cancer Institute specializing in gene expression, chromatin, and signal transduction.

ORCID

Top concepts

Publications per year

2006–2018

7

Publications

7

The STAT5 inhibitor pimozide decreases survival of chronic myelogenous leukemia cells resistant to kinase inhibitors

Erik A. Nelson, Sarah R. Walker, Ellen Weisberg et al. · Blood · 2011 · 268 citations · Full text

Enhancer Architecture and Essential Core Regulatory Circuitry of Chronic Lymphocytic Leukemia

Christopher J. Ott, Alexander Federation, Logan S. Schwartz et al. · Cancer Cell · 2018 · 168 citations · Full text

, , +10

Survival of Del17p CLL Depends on Genomic Complexity and Somatic Mutation

Lijian Yu, Haesook T. Kim, Siddha Kasar et al. · Clinical Cancer Research · 2016 · 92 citations · Full text

Combination of two anti‐<scp>CD</scp>5 monoclonal antibodies synergistically induces complement‐dependent cytotoxicity of chronic lymphocytic leukaemia cells

Josephine L. Klitgaard, Klaus Koefoed, Christian H. Geisler et al. · British Journal of Haematology · 2013 · 30 citations · Full text

<scp>MYD</scp>88 L265P mutations identify a prognostic gene expression signature and a pathway for targeted inhibition in <scp>CLL</scp>

Ma. Reina Improgo, Bethany Tesar, Josephine L. Klitgaard et al. · British Journal of Haematology · 2018 · 22 citations · Full text

Rows per page

1–5 of 7